Programme

Track Programme

Block 1: Brave New World of Healthcare
“LIVE” Opening Ceremony + Keynote + Panel Discussion

Programme on Day 1: 7 October 2021, Thursday
Session 1: 0845 – 1015hrs

Topic 1 : Welcome Address

Speaker :
Prof Philip Choo , Group Chief Executive Officer, National Healthcare Group; Senior Consultant, Department of Geriatric Medicine, Tan Tock Seng Hospital

Topic 2 : Keynote Lecture: Community, Family & Health

Speaker :
Mr Masagos Zulkifli , Minister for Social and Family Development, Second Minister for Health, Minister-in-Charge of Muslim Affairs, Republic of Singapore

Topic 3 : Panel Discussion: Reinventing the Continuum of Healthcare

Moderator :
Ms Salma Khalik , Senior Health Correspondent, The Straits Times
Panellist :
A/Prof Kenneth Mak , Director of Medical Services, Ministry of Health
Prof Philip Choo , Group Chief Executive Officer, National Healthcare Group; Senior Consultant, Department of Geriatric Medicine, Tan Tock Seng Hospital
A/Prof Jeremy Lim , Director, LIGHT, Saw Swee Hock School of Public Health, NUS
Incentivising Health / Preventive Care: Plenary + Panel Discussion (Broadcast Date – TBC)

Topic 1 : Plenary: Health of Our Nation

Speaker :
Adj Prof Derrick Heng , Deputy Director of Medical Services, Public Health Group, Ministry of Health

Topic 2 : Panel Discussion: How To Optimally Incentive Health Promotion And Disease Prevention

Moderator :
Prof Teo Yik Ying , Dean, Saw Swee Hock School of Public Health, National University of Singapore
Panellist :
Adj Prof Derrick Heng , Deputy Director of Medical Services, Public Health Group, Ministry of Health
Dr Alan Ong , Medical Director, AIA Singapore
Dr Joanne Yoong , Senior Economist and Director, University of Southern California; Founder and CEO, Research for Impact Singapore
Mr Zee Yoong Kang , Chief Executive Officer, Health Promotion Board
Block 2: What We Learnt from Covid-19?
NCID: Are We There Yet? (Broadcast Date – TBC)

TRACK SYNOPSIS

More Information Coming Soon.

Track Lead :
Prof Leo Yee Sin , Executive Director, Senior Consultant,National Centre for Infectious Diseases

Topic 1 : Epidemiology And Impact Of COVID-19 - Where We Are Now and Where We Will Be

Speaker :
Prof Vernon Lee , Director, Communicable Diseases Division, Ministry of Health
  • Epidemiology and impact of COVID-19
  • Current control measures in Singapore and it’s effectiveness
  • Future plans to live with COVID-19

Topic 2 : How Modelling Guides Policy

Speaker :
A/Prof Alex Cook , Associate Professor, Saw Swee Hock School of Public Health, National University of Singapore
  • Modelling
  • Infectious disease epidemics
  • Policy making

Topic 3 : NCID & Covid-19 Challenges

Speaker :
Prof Leo Yee Sin , Executive Director, Senior Consultant, National Centre for Infectious Diseases
  • Elusive Virus
  • Clinical Features
  • Health System Response
Responding to Surge in COVID-19 Cases in Singapore at the Height of the Pandemic (Broadcast Date – TBC)

TRACK SYNOPSIS

In early April 2020 during the beginning of the COVID-19 pandemic in Singapore, there was a surge in the number of COVID-19 cases, largely due to rapid transmission within the migrant worker dormitories. This led to a significant strain in the healthcare system and a need to increase the capacity and care for COVID-19 positive patients.

The programme for this track presents an overview on the response to the surge in COVID-19 cases where a multidisciplinary, inter-agency team set up, operationalised and managed a COVID-19 Community Care Facility (CCF) in Expo and provided clinical care of COVID-19 positive patients.

Our speakers will share how they engineered the infrastructure, workflows and processes and operationalised the largest CCF in a non-healthcare facility, making it fit for purpose. Speakers will also share on the various innovations implemented to support the clinical teams and processes that enabled the care teams to deliver high quality care and achieve excellent clinical outcomes.

Track Lead :
Dr Wong Kirk Chuan , Chief Operating Officer,Woodlands Health
Chairperson :
Mr Ho Chun Keong , (Acting) Director, Allied HealthWoodlands Health

Topic 1 : Caring For Patients In The Expo Community Care Facility (Nursing)

Speaker :
Mr Muhammad Faiz Bin Abdul Rahmat Mordiffi , Nurse Manager, Nursing Service Planning, Woodlands Health
  • Patient monitoring
  • Nursing care for patients in the CCF
  • Chronic disease management
  • Wellness activities

Topic 2 : HealthTech Innovations Against COVID-19

Speaker :
Mr Chua Chee Yong , Director, SHAPE (Strategy, HITMAP, Alliance, Planning and Exploration), Integrated Health Information Systems (IHiS)
  • How we can transform healthcare through smart technology
  • Examples of IHiS projects and challenges addressing the pandemic
  • Future plans of IHiS towards the healthcare sector in Singapore

Topic 3 : Setting Up CCF – Making Expo Fit For Purpose As A CCF Woodlands Health Campus

Speaker :
Dr Kalisvar Marimuthu , Senior Consultant, Infection Prevention and Control Office, Woodlands Health
  • Ventilation and air hygiene
  • Environmental hygiene
  • Clean-contaminated flow
  • Challenges in IPC implementation

Topic 4 : Caring For Patients In The Expo Community Care Facility (Medical)

Speaker :
Dr Toh Han , Consultant, Department of Anaesthesiology, Woodlands Health
  • How we set up the CCF
  • Daily events in the CCF
  • Patient care and management in the CCF
How Science and Research Impacted Policy and Practice in the Pandemic (Broadcast Date – TBC)

TRACK SYNOPSIS

From the first known cases in December 2019 to 1 billion fully vaccinated people by July 2021. From an unknown pathogen to rapid self-testing. From experimental treatments with repurposed drugs to highly specific antibody mimetics. From anosmia and ageusia to hundreds of millions of cases and an untold number of deaths. From a horseshoe bat to the world.

In this session the speakers will discuss research from Singapore which has helped shape our understanding of COVID-19 and impacted pandemic policy and clinical practice.

Track Lead :
Dr Barnaby Young , Head, Infectious Disease Research Ward; Consultant, National Centre for Infectious Diseases

Topic 1 : COVID-19 Variants And Vaccines: Clinical Findings From The PROTECT And SCOPE Studies

Speaker :
Dr Barnaby Young , Head, Infectious Disease Research Ward; Consultant, National Centre for Infectious Diseases
  • Since January 2020 more than 750 individuals have joined the PROTECT study of COVID-19
  • Clinical studies have included investigating the presentation, natural history, risk factors for severe infection and long COVID
  • The follow up SCOPE study seeks to understand the immune response in up to 1000 COVID-19 vaccine recipients

Topic 2 : Evolving Serological Platforms in Responding to COVID-19: From LIPS to sVNT/cPass

Speaker :
Prof Linfa Wang , Professor, Programme in Emerging Infectious Disease, Duke-NUS Medical School
  • The role of serology in combating COVID-19
  • Binding antibodies versus neutralizing antibodies
  • Vaccine efficacy and correlate of protection

Topic 3 : Mechanisms of SARS-CoV-2 Pathogenesis

Speaker :
Prof Lisa F.P. Ng , Executive Director, A*STAR Infectious Diseases Labs (A* ID Labs)
  • Infection
  • Immunity
  • Therapies
Communicating a Pandemic in the Age of Social Media (Broadcast Date – TBC)

TRACK SYNOPSIS

The COVID-19 pandemic is a public health crisis that is unprecedented in its global scope, severity, and duration. In this protracted crisis, there have been serial and major changes and consequential interactions between outbreak intensity, government response and population behaviours.

We cover some public health interventions in Singapore that required the cooperation of the public, including advisories and mandates on mask use, sickness leave and quarantine policies, roll-out of vaccines, and use of self-test kits. While these interventions are generally useful to bring a COVID-19 epidemic under control, we illustrate how population behaviours to well-meaning interventions could in some cases may also have unintended consequences that also hinder control of the epidemic.

We then reflect on the case for frequent sensing of receptiveness towards these interventions ahead of and after implementation, as well as the need to monitor for and mitigate any potential unintended consequences.

Track Lead :
Dr Mark Chen , Consultant, National Public Health and Epidemiology Unit, National Centre for Infectious Diseases

Topic 1 : COVID-19 Infodemic: Enabling Communication Science Enquires through Social Media Analytics

Speaker :
Prof May Oo Lwin , President’s Chair Professor, Wee Kim Wee School of Communication and Information, Nanyang Technological University

How do populations respond to the pandemic throughout its development? This presentation discusses how our research has leveraged multimodal emotion analysis technologies and social media data in the context of COVID-19 communication science research. Prof Lwin will share findings from her team’s interdisciplinary research which investigated a number of theoretical and translational questions surrounding the public, media and government responses to the COVID-19 infodemic.

 

Topic 2 : Understanding Drivers Of COVID-19 Vaccine Hesitancy In The Singapore Population: SOCRATES Cohort

Speaker :
A/Prof Konstadina Griva , Associate Professor, Health Psychology and Behavioural Medicine, Lee Kong Chian School of Medicine; President of Society Behavioural Health Singapore

Topic 3 : Unintended Consequences, Vaccine Optimism, and Why U-Turns are Ok

Speaker :
Dr Mark Chen , Consultant, National Public Health and Epidemiology Unit, National Centre for Infectious Diseases
  • In responding to pandemics, policy makers must make difficult choices which require the public’s support and understanding
  • Regular sensing of the population’s behaviour and response to health messaging can help ensure interventions are being supported
  • It can also detect unintended consequences of control measures that may necessitate adjustments to existing interventions
“LIVE” What We Learnt from COVID-19? : Plenary + Panel Discussion

Programme on Day 1: 7 October 2021, Thursday
Session 4: 1500 – 1615hrs

Topic 1 : Plenary: What Does The COVID-19 Pandemic Tell Us About Health Systems And Preparedness?

Speaker :
Prof Tan Chorh Chuan , Chief Health Scientist, Ministry of Health Executive Director, MOH Office for Healthcare Transformation

Prior to COVID-19, we had mostly taken a dichotomous approach to 3 sets of key issues namely (1) The SARS vs influenza paradigm of pandemic control; (2) The development of 2 key global priorities in the form of Universal Health Coverage and Epidemic Preparedness; and (3) The building of basic research capabilities vs their rapid translation into real world applications. The COVID-19 pandemic has shown these to be false dichotomies. The presentation argues that we need to develop a new SARS plus Flu paradigm of pandemic prevention and control.  Instead of separate thrusts in UHC, epidemic preparedness and health system development, we must focus on integrated health ecosystems as a critical goal, The pandemic has also shown us new ways by which we can transform the complex process of bringing basic science strengths and discoveries into beneficial real world application.

  • A new SARS plus flu paradigm of pandemic prevention and containment
  • A well integrated health ecosystem is critical
  • Implications for health system transformation

Topic 2 : Panel Discussion: New Models of Partnership in a Post-Covid World

Moderator :
A/Prof David Lye , Director, Infectious Disease Research and Training Office, National Centre for Infectious Diseases; Associate Professor, Lee Kong Chian School of Medicine
Panellist :
Dr Richard Hatchett , Chief Executive Officer, Coalition for Epidemic Preparedness Innovations (CEPI) ,
Prof Leo Yee Sin , Executive Director, Senior Consultant, National Centre for Infectious Diseases
Prof Peter Piot , Professor of Global Health, London School of Hygiene & Tropical Medicine; Distinguished Visiting Professor in Medicine, National University of Singapore
Dr Soumya Swaminathan , Chief Scientist, World Health Organization
Education
Learning from Disruption in Medical Education (Broadcast Date – TBC)

TRACK SYNOPSIS

Among its many other impacts, COVID-19 significantly disrupted workplace- and campus-based medical education. Students were withdrawn from bedside teaching and redirected to online learning or, in some countries, to support activities such as staffing helplines or supporting frontline staff. Yet while core educational experiences were disrupted, new educational experiences were introduced.

In this track we provide examples of change in response to Covid-19 and reflect on the short- and longer-term consequences and impacts of these and other changes at a systems, group and individual level.

Our purpose in doing so is to consider how we can use our learning during Covid-19 to change things fundamentally in positive ways for the future of medical education. What was lost and what was gained? What is truly essential? What can be changed for the better going forward?

The COVID-19 crisis seems to be passing. Our challenge henceforth is to learn from the choices and sacrifices necessitated by the pandemic.

Track Lead :
Professor Jennifer Cleland , President’s Chair in Medical Education and Vice-Dean (Education),Lee Kong Chian School of Medicine,Nanyang Technological University
Chairperson :
Professor Jennifer Cleland , President’s Chair in Medical Education and Vice-Dean (Education),Lee Kong Chian School of Medicine,Nanyang Technological University

Topic 1 : Turning A Crisis Into An Opportunity: Covid-19 And Medical Education

Speaker :
Professor Jennifer Cleland , President’s Chair in Medical Education and Vice-Dean (Education), Lee Kong Chian School of Medicine, Nanyang Technological University
  • COVID-19 significantly disrupted workplace- and campus-based medical education.
  • We provide examples of change in response to Covid-19 and reflect on the short- and longer-term consequences and impacts of these and other changes at a systems, group and individual level.
  • Our purpose in doing so is to consider how we can use our learning during Covid-19 to change things fundamentally in positive ways for the future of medical education.

Topic 2 : Forging New Path: Learning Of Clinical Skills In The Pandemic

Speaker :
Adj A/Prof Koh Nien Yue , Assistant Dean for Year 3, Lee Kong Chian School of Medicine, Nanyang Technological University; Senior Consultant, Department of General Medicine, Tan Tock Seng Hospital
  • Learning challenges during the pandemic
  • Adaptations, strategies and innovations
  • Constraints and future pathway

Topic 3 : Using Digital Tools To Meet The Challenges Of Medical Education

Speaker :
Dr Ng Kian Bee Head of Digital Learning, Lee Kong Chian School of Medicine, Nanyang Technological University; Co-Director, ALIVE (gAmes for heaLth InnoVations cEntre)
  • Learning challenges brought on by COVID-19
  • Examples in overcoming the challenges through the use of digital tools
  • New norm of learning beyond COVID-19

Topic 4 : The Responsive Digital-Chain Of Continuous Learning (A Digital-Led Strategy)

Speaker :
Mr Ben Lee , Manager, NHG College, National Healthcare Group
  • Addressing the needs of 21st century learners
  • Appreciating the leading trend of Digital Learning
  • Accelerating ‘Tech Tool Series’ initiatives in NHG Education
Stratifying Health Care
Stratifying Health Care : PLENARY + PANEL DISCUSSION (Broadcast Date – TBC)

Plenary Synopsis

In the past two decades, rapid advances in biomedical science and information technology have put clinical medicine on a cross-road. Our understanding of disease classification and pathophysiological mechanisms is re-written by whole-genome sequencing, epigenetic and meta-genomic analysis.

On the other, expansion of computer memories, speed and analysis, invention of smart phone and internet of things have changed every aspect of our life including healthcare. Genomic data, clinical presentations, diagnostic images and scientific research can be integrated to produce the best patient-centred management protocol.

Before precision medicine can be implemented into daily clinical practice, trust between machine, algorithm, genomics data and patients-physicians-healthcare provider need to be built. Ethical, social and legal issues of data-driven and artificial intelligence guided machine need to be resolved. Cost-effectiveness of Precision Medicine needs to be demonstrated by testing the new diagnostic and treatment modalities can be translated into better outcome at an affordable price. Medical education needs to be reformed and clinical training should include how to work with technology.

  • Technology and development of biomedical sciences have made personalized care of medical condition a reality
  • Proof of improved clinical outcome and cost-effectiveness is yet to be confirmed.
  • Trust on machine learning in making life-and-death decision is still weak and algorithm needs to be tested in different ethnic groups and different jurisdiction.
  • Ethical, social and legal issues of data-driven and artificial intelligence is unclear and, in many areas undefined.

Topic 1 : Plenary: Precision Medicine in 2021: Opportunities and Challenges

Speaker :
Prof Joseph Sung , Dean, Lee Kong Chian School of Medicine Senior Vice President (Health and Life Sciences), Nanyang Technological University

Topic 2 : Panel Discussion: Stratifying Patients for Better Outcomes

Moderator :
Prof Benjamin Seet , Deputy Group Chief Executive Officer (Education and Research), Group Chief Research Officer, National Healthcare Group
Panellist :
Prof John Chambers , Professor of Cardiovascular Epidemiology Chief Investigator for HELIOS and SG100K, Lee Kong Chian School of Medicine, Nanyang Technological University
Dr Lisa Ooi , Vice President, Healthcare & Wellness, Economic Development Board
Prof Joseph Sung , Dean, Lee Kong Chian School of Medicine Senior Vice President (Health and Life Sciences), Nanyang Technological University
Prof Patrick Tan , Executive Director, Genome Institute of Singapore
Improving Surgical Outcomes: Journeys from Isolation to Collaboration (Broadcast Date – TBC)

TRACK SYNOPSIS

Collaboration in health care is a complex partnership and the benefits are well validated. Patient care in surgical disciplines is continuing to evolve. Only a few decades ago, surgeons had well-defined but relatively isolated clinical practices.

This practice of isolated care followed a linear care pathway wherein a sequence of clinical events occurred in a specific order, one at a time, as the patient moved from diagnosis to preoperative care, to surgery, and then to postoperative care and discharge. At each step, the patient’s care used to be determined by the individual clinical judgment and practice preferences of the specialist managing that phase of care. Although this historical model of patient care addressed the surgical care needs, it has been shown by evidence that isolated care is suboptimal, inefficient, and costly.

New models of collaborative surgical care not only bring together multiple clinicians of different specialities like surgeons, anesthesiologists, physicians but also other healthcare professionals like nurses, physiotherapists, pharmacists, and others by redesigning care pathways and create more collaborative and efficient delivery of care to improve outcomes.

Collaboration in healthcare is an ongoing journey, that takes time and effort from the entire team, to develop. This continuous journey of improvement is not without problems and conflicts. Much of the literature on collaboration describes what it should look like as an outcome, but little is discussed about how to approach the developmental process of collaboration and the challenges faced. The important question which needs to be answered is: How can we collaborate more effectively?

In this track, we will learn from some of the pioneers of collaborative healthcare in Singapore and how their journeys have led to improved outcomes in surgical patients.

Track Lead :
Adj Asst Prof Surendra Mantoo , Senior Consultant, Department of General Surgery, Khoo Teck Puat Hospital

Topic 1 : Improving Surgical Outcomes in Geriatric Patients Through Collaboration: A Continuing Journey of More Than 10 Years

Speaker :
A/Prof Tan Kok Yang , Head; Senior Consultant, Department of General Surgery, Khoo Teck Puat Hospital
  • Key principles of geriatric surgical care
  • Our journey over 10 years
  • The way forward

Topic 2 : Improving Surgical Outcomes in Total Knee Replacement Surgery Through Collaboration: Start of A New Journey

Speaker :
Dr Alvin Tan , Consultant, Department of Orthopaedic Surgery, Khoo Teck Puat Hospital
  • Painful, Suffering, Last Resort
  • These were what we thought of when we say total knee replacement
  • As a transdisciplinary team, we transform this to a painless journey that can change a patient’s life

Topic 3 : Going Beyond Evidence Based Protocols: What Is The Key To Success In Perioperative Recovery Programs?

Speaker :
Dr How Kwang Yeong , Senior Consultant, Department of General Surgery, Tan Tock Seng Hospital
  • Success of perioperative recovery programs goes beyond evidence-based protocols.
  • Stakeholders need to be engaged at all levels.
  • Partnerships between stakeholders are key.
Appreciating Multimorbidity: A Game Changer for Primary Care (Broadcast Date – TBC)

TRACK SYNOPSIS

Multimorbidity is an increasing phenomenon primary care clinicians face with daily in their consultations with patients. In the primary care setting, Family Physicians manage patients holistically, providing care that boundary spans across organ systems. In doing so, considerations of multiple chronic conditions often arise and affect treatment options and goals. We intend to showcase both the broad strategies of understanding the care implications of multimorbidity as well as the current term initiatives in locally performed research that will distil crucial knowledge to build a future care system that will provide better care for such patients.

Track Lead :
Dr Darren Seah , Senior Consultant Family Physician; Director, Family Medicine Development, National Healthcare Group Polyclinics

Topic 1 : Multimorbidity: The Findings From Research Work Done in Singapore Primary Care

Speaker :
Dr Lee Eng Sing , Senior Consultant Family Physician, National Healthcare Group Polyclinics
  • Definition of multimorbidity
  • Prevalence of multimorbidity
  • Burden of multimorbidity

Topic 2 : Minimally Disruptive Medicine (MDM) - The Importance Of Person Centred Care For People With Multimorbidity

Speaker :
Professor Frances Mair , Norie Miller Professor of General Practice, Institute of Health and Wellbeing, University of Glasgow
  • Multimorbidity
  • Treatment Burden
  • Concepts underpinning Minimally Disruptive Medicine

Topic 3 : Healthcare Providers’ Views on Using Clinical Practice Guidelines in the Management of Patients with Multimorbidity

Speaker :
Dr Sim Sai Zhen , Associate Consultant, Family Physician, National Healthcare Group Polyclinics
  • Benefits of using clinical practice guidelines in patients with multimorbidity
  • Challenges of using clinical practice guidelines in these patients
  • Overcoming the challenges

Topic 4 : Q&A (Track 4B)

Metabolic Health & Diabetic Management (Broadcast Date – TBC)

TRACK SYNOPSIS

With the declaration of war on diabetes by Ministry of Health – there has been a concerted effort across NHG to prevent our existing diabetic patients from developing complications; but also in keeping the onset of diabetes at bay among our population.

In line with the NHG River-of-Life’s (RoL’s) Care Segments, and with the NHG DM Steering Committee’s (DMSC) work straddling “Living with Illness & Living Well”, this track will focus on sharing of the Diabetes, Hypertension and dyslipidaemia (DHL) strategy and measurement, and the ongoing efforts of DMSC & its workgroups to achieve the goal of “Creating a healthier Singapore population free from the burden of diabetes and conditions related to the metabolic syndrome.”

Track Lead :
A/Prof Lim Su Chi , Senior Consultant, Diabetes Centre, Admiralty Medical Centre

Topic 1 : Introduction of Diabetes, Hypertension and dysLipidemia (DHL) Strategy and Measurement

Speaker :
Adj A/Prof Daniel Chew , Assistant Chairman Medical Board (Medical Manpower Development), Senior Consultant, Department of Endocrinology, Tan Tock Seng Hospital; Chairperson, DM Steering Committee, National Healthcare Group
  • The sharing on DHL strategy map will highlight the overall approach that the DMSC has aligned to in order to improve diabetes and metabolic care.
  • Working with HSOR, the DHL measurement will highlight the evaluation efforts within DMSC to track and monitor interventions to inform future work.

Topic 2 : One DM Care Mdel through Standardising and Harmonising DM Education for Patients and Training for HCPs

Speaker :
A/Prof Michelle Jong , Group Chief Education Officer, National Healthcare Group Assistant Chairman Medical Board (Education), Senior Consultant, Department of Endocrinology, Tan Tock Seng Hospital
Dr Hoi Wai Han , Senior Consultant & Head, Medical Services, Department of Endocrinology, Woodlands Health
  • Education is not a panacea for the failure to achieve health outcomes desired
  • This session will showcase 2 projects in Diabetes, i.e. (1) Diabetes School and (2) NHG e-Learning Curriculum for Healthcare Professionals (HCPs) Project
  • Where Education is headed in the next few years

Topic 3 : Weight Management Across Care Continuum

Speaker :
Dr Donna Tan , Family Physician-Associate Consultant & Assistant Director, Clinical Services, National Healthcare Group Polyclinics
  • This session will showcase the main programmes and evaluation from the Tiered Weight Management (TWM) & War on Diabetes – Community Intervention Programmes (WOD-CIP) workgroups.
  • TWM: Tiered weight management across the care continuum
  • WOD-CIP: Holistic wellness and weight management programmes in the well/at-risk population

Topic 4 : Improving Diabetes Care in the Population with Augmented Glucose Monitoring

Speaker :
Dr Serena Low , Consultant, Clinical Research Unit, Khoo Teck Puat Hospital
  • This session will showcase interim results from the Augmented Glucose Monitoring Programme, a community based diabetes care intervention in the North
  • The programme, spearheaded by the Yishun-Health Population Health & Community Transformation and Clinical Research Unit teams, aims to improve diabetes care in the community through the development and use of a self-management toolkit and to leverage upon community resources.
  • The toolkit contains self-management technologies, including continuous glucose monitoring by the Libre Flash Glucose Monitoring system, customised food diaries and educational materials designed to increase understanding of condition and to promote lifestyle changes

Topic 5 : Diabetic Foot in Primary and Tertiary (DEFINITE) Care

Speaker :
Dr Joseph Lo , Project Lead, DEFINITE Care, Consultant, Department of Surgery, Woodlands Health
  • This session will showcase what has been done at NHG to improve diabetic foot care and DEFINITE primary and tertiary collaboration in diabetic foot care
  • The DEFINITE Care Project aims to coordinate primary and tertiary care for patients with diabetic foot ulcers to prevent amputations and decrease the economic and disease burden within NHG
Innovation in Clinical Care
Palliative Care: Animation, Rehabilitation, Collaboration & Digitalisation (Broadcast Date – TBC)

Track Synopsis

Palliative medicine strives to provide comfort and support to both patients and their families. As a relatively new specialty, palliative medicine constantly seeks to transform and improve inter-disciplinary collaboration across various care settings.

This however, has been challenged by the ongoing COVID-19 pandemic, which has massively disrupted the way healthcare is traditionally delivered. The once nascent field of telehealth for example, has now become mainstream rather than a novel.  As a specialty that prides itself on the human touch, the practice of palliative medicine has also had to adapt to the widespread use of video conferencing and video consultation. 

In this track, we will focus on two aspects. In the first, we will describe novel collaborations with both the acute surgical team as well as the rehabilitation team within Khoo Teck Puat Hospital. Sharing the stories of real-life patients, we will present our experience with this unique cross-disciplinary model of care.

The second part of the track will focus on how palliative care has had to adopt to the new normal with the use of technology and video-conferencing as a useful adjunct in education, clinical consultation, nursing and even advance care planning. Using real life examples, we will illustrate how technology aids our ongoing partnership in the delivery of end-of-life care for residents in nursing homes.

Track Lead :
Dr Mansha Khemlani , Senior Consultant, Department of Geriatric Medicine, Khoo Teck Puat Hospital
Dr Laurence Tan , Consultant, Department of Geriatric Medicine, Khoo Teck Puat Hospital
Dr Chua Zi’En Ruth , Consultant, Department of Geriatric Medicine, Khoo Teck Puat Hospital

Topic 1 : Palliative Surgery Collaboration

Speaker :
Dr Chua Zi’En Ruth , Consultant, Department of Geriatric Medicine, Khoo Teck Puat Hospital
  • Palliative Surgery in Advanced Cancer
  • Decision Making in Palliative Surgery
  • Future Directions/Areas of Research 

Topic 2 : Creating a Palliative Ready Rehabilitation Team

Speaker :
Ms Melissa Ng , Senior Physiotherapist, Rehabilitation Services, Yishun Community Hospital
  • Current challenges and gaps among therapists
  • Therapists palliative training framework
  • Evaluation of therapists’ knowledge and attitude

Topic 3 : Use of Animation as a Tool for Education in Palliative Care

Speaker :
Ms Lim Yujun , Assistant Manager, GeriCare, Khoo Teck Puat Hospital
  • Quality of education can be enhanced with the inclusion of animations in teaching.
  • Knowledge on Palliative Care can be delivered in a fun and engaging manner.
  • Concepts can be better visualised via multimedia elements which help to make topics more comprehensible.

Topic 4 : Embracing Technology to Support End-Of-Life Care in the Nursing Homes

Speaker :
Ms Sim Lai Kiow , Nurse Clinician, Palliative Care and Support Service, Khoo Teck Puat Hospital
  • Introduction of GeriCare
  • Provision of EOL care during COVID-19
  • Enhancing training with PowerFacts
Biologics Revolution in Skin (Broadcast Date – TBC)

TRACK SYNOPSIS

The therapeutic landscape for skin diseases is rapidly changing. We are currently in the middle of a biologics revolution that is providing transformative changes to the way that patients with dermatological conditions are treated. Atopic dermatitis (AD) is a common skin disease affecting up to 20% of the Singapore population, with significant clinical heterogeneity and numerous molecular subtypes. There is a number of new treatment options available for atopic dermatitis patients that have long suffered with chronic, recalcitrant disease symptoms, however knowledge gaps still remain. In this session we will hear about next generation treatment options that target the major cytokines driving skin inflammation and chronic itch that are central nodes of disease pathomechanism. We will also hear about the current status of patient care for atopic dermatitis in Singapore and the latest progress that is being made. Although new therapies are available or on the horizon for atopic dermatitis, additional research is still required especially in understudied ethnicities, rarer phenotypic subtypes and for patients that do not respond to current biologics therapies.

Track Lead :
A/Prof Steven Thng , Senior Consultant, National Skin Centre; Chief Dermatologist, Skin Research Institute of Singapore
Dr John Common , Principal Investigator, Skin Research Institute of Singapore, Agency for Science, Technology & Research (A*STAR)

Topic 1 : Biologics In Atopic Dermatitis

Speaker :
Prof Emma Guttman-Yassky, M.D., Ph.D. , Waldman Professor and System Chair, The Kimberly and Eric J. Waldman, Department of Dermatology; Director, Center of Excellence in Eczema Director, Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai
  • Understanding atopic dermatitis
  • Understanding how biologic treatments work in atopic dermatitis
  • Applying biologic treatments to atopic dermatitis

Topic 2 : Pruritus In Atopic Dermatitis: IL-31 And Other Mediators

Speaker :
Prof Kenji Kabashima , Chair, Professor, Department of Dermatology, Kyoto University Graduate School of Medicine; Principal Investigator, Skin Research Institute of Singapore/SIgN, Agency for Science, Technology & Research (A*STAR)
  • Pathogenesis of pruritus in atopic dermatitis
  • Role of IL-31 in pruritus
  • Novel therapeutic target of IL-31 in pruritus of atopic dermatitis

Topic 3 : Emerging Therapeutics Of Atopic Dermatitis - Our Local Experience

Speaker :
Dr Yew Yik Weng , Consultant, National Skin Centre
  • Many new atopic dermatitis therapeutics are in the pipeline
  • IL-13 and IL-31 Biologics as well the oral JAK inhibitors will become available in the next 1 to 2 years
  • It is important to be mindful of comparative efficacy and cost effectiveness of these new AD therapies in our local Asian setting
Mobility, Frailty & Falls: Optimise to Maximise (Broadcast Date – TBC)

Track Synopsis

Aging and illness can cripple some people on the one hand, and yet be the catalyst to setting some others on a journey to health and recovery through rehabilitation, reframing and making lifestyle changes. Our speakers will share how we can optimise mobility to retard frailty and prevent falls in order to maximise the potential of our patients and population at large.

Track Lead :
Dr Teoh Chin Sim , Clinical Director & Senior Consultant,Sports & Exercise Medicine,Khoo Teck Puat Hospital Khoo Teck Puat Hospital

Topic 1 : From the Paralympics to Public Health: Using Sport to Enhance Fitness in Adults with Disabilities

Speaker :
Asst Prof Cheri Blauwet , Assistant Professor, Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Harvard Medical School

The goals of this lecture include:

  • To describe the impact of sedentary lifestyles on the health of people with disabilities globally
  • To outline the importance of considering adaptive and Paralympic sport opportunities as a key component of disability rights and health promotion
  • To describe what clinicians, researchers and health professionals can do to promote physical activity participation for people with disabilities

Topic 2 : Preserving Musculoskeletal Health for Healthy Aging

Speaker :
Dr Su Su , Consultant, Department of Geriatric Medicine, Khoo Teck Puat Hospital
  • Locomotor function and healthy aging
  • When muscle and bone face each other
  • Osteosarcopenia: impact worse than sarcopenia

Topic 3 : Allied Health Professionals’ Courageous Moves in Advancing Clinical Care

Speaker :
Ms Yong Limin , Senior Principal Physiotherapist, Healthcare Manpower Division, MOH Holdings
  • The needs of our time
  • Brief introduction of the progress
  • The impact of the moves

Topic 4 : Guide the Walk, Hold the Fall Anytime Anywhere

Speaker :
Dr Loh Yong Joo , Head & Senior Consultant, Department of Rehabilitation Medicine, Tan Tock Seng Hospital
  • Innovations and enabling technologies for mobility assessment and intervention
  • Predict, prevent and protect Individuals from falling using enabling technologies
  • Opportunities and challenges in the adoption of healthcare technologies
Psychiatry in a Post COVID-19 World (Broadcast Date – TBC)

Track Synopsis

COVID-19 has changed the way patients interact with and receive care from mental healthcare providers. This session will explore the various ways mental health has evolved to address the unique challenges of the COVID-19 pandemic and chart a path from illness to wellness.

Track Lead :
Dr Tor Phern Chern , Senior Consultant; Head, Neurostimulation Service, Institute of Mental Health

Topic 1 : Bridging The Treatment Gap For OCD: Internet-Based Cognitive Behavioural Therapy (iCBT) May Be The Answer

Speaker :
Dr Jackki Yim , Senior Clinical Psychologist, Psychology Department/ Department of Mood and Anxiety, Institute of Mental Health
Ms Tammie Kwek , Senior Clinical Psychologist, Department of Psychology, Institute of Mental Health
  • Treatment barriers for OCD
  • Innovative ways to deliver CBT for OCD
  • The efficacy of iCBT for adults with OCD in Singapore: A pilot study

Topic 2 : Clinical Service of Virtual Cognitive Behavioural Group Therapy (PsychUp Online)

Speaker :
Mr Lim Wee Onn , Senior Clinical Psychologist, Department of Mood and Anxiety, Institute of Mental Health
  • Translation of in-person CBT group therapy to online
  • Pre and Post of outcome measures
  • Limitations and challenges of virtual group therapy

Topic 3 : Health Promotion Through Sports - A Partnership Between IMH & RP

Speaker :
Adj Asst Prof Alex Su , Vice Chairman Medical Board (Clinical Quality); Chief, Department of Recovery Care, Institute of Mental Health
Mr Aziz Bin Abdul Hamed , Chief Nurse Clinician, Nursing, Institute of Mental Health
Mr Aaron Chen Angus , Assistant Programme Chair (Health Management and Promotion), School of Sports, Health and Leisure, Republic Polytechnic
  • Implementation of Sports and Fitness Programmes to Promote Holistic Health in the Long-Stay Wards at IMH – presented by Dr Alex Su
  • Community Engagement and Volunteer Activities for RP Students at IMH – presented by Aziz bin Ab Hamed
  • Virtual Events as Youth Engagement Touch Points to Promote Mental Health Awareness and Advocacy, and to Combat Mental Health Stigma – presented by Aaron Chen Angus

Topic 4 : The Importance of Real World Evidence in treating Mental Health And Chronic Disease

Speaker :
Mr Nawal Roy , Founder & Chief Executive Officer, Holmusk
  • Despite rising prevalence of behavioral health disorders, progress has lagged behind other disease areas in the last few decades
  • There is a debilitating evidence gap in behavioral health that inhibits research and innovation
  • Using innovative AI-powered analytics, we can unlock powerful insights that drive Real-World Evidence and new solutions for behavioral health
Innovation in Clinical Care : PLENARY + PANEL DISCUSSION (Broadcast Date – TBC)

Plenary Synopsis

To truly individualise patient treatment, there are a number of considerations to be made. For example, once a treatment regimen is selected, patient responses can be dynamic and evolve over time. In the context of combination therapy, which is a cornerstone of patient care for indications ranging from oncology to chronic disease, drug synergy can be dose-dependent, time-dependent, and patient-specific. In addition to pharmacologic treatment, dynamic patient responses to therapy can be observed for digital cognitive health interventions, also known as digital therapeutics, as well. Importantly, optimising these and other factors can drive substantial inter- and intra-patient variability in treatment outcomes. To address these challenges, the emergence of digital medicine is making it possible to optimise N-of-1 regimen design for patients, and subsequently administer these regimens in a dynamic fashion that evolves alongside the patient. Of note, these strategies can also empower new ways to prospectively acquire patient data, and how this data can be harnessed to modulate intervention, from drug selection to dynamic dosing. Successfully integrating digital medicine-optimised treatment into clinical workflows will ultimately be catalyzed by sustained interdisciplinary engagement between multiple communities spanning clinical, technology, behavioural sciences, healthcare economics, and implementation sciences, and beyond. Towards these objectives, this talk will address our recent clinical development studies for both combination therapy and digital therapy driven by interdisciplinary engagement at WisDM and N.1 to dynamically tailor patient-specific treatment outcomes, reduce healthcare costs, and increase accessibility to practice-changing and optimised medicine.

Topic 1 : Plenary: Harnessing Digital Medicine to Optimise N-of-1 Healthcare

Speaker :
Prof Dean Ho , Provost’s Chair Professor Director, The N.1 Institute for Health (N.1) Director, The Institute for Digital Medicine (WisDM) Head, Department of Biomedical Engineering, Department of Pharmacology, National University of Singapore
  • Technology is changing the way that therapies are developed and administered so that regimens can evolve alongside the patient.
  • Integrating digital medicine-based optimisation into clinical workflows may pinpoint more responders to therapy.
  • Digital medicine is making accessible N-of-1 healthcare a reality.

Topic 2 : Panel Discussion: Harnessing Digital Technology for Clinical Innovation

Moderator :
Adj A/Prof Tan Cher Heng , Assistant Chairman Medical Board (Clinical Research and Innovation), Senior Consultant, Department of Diagnostic Radiology, Tan Tock Seng Hospital
Panellist :
A/Prof Chong Phui-Nah , Chief Executive Officer, National Healthcare Group Polyclinics & Primary Care
Prof Dean Ho , Provost’s Chair Professor Director, The N.1 Institute for Health (N.1) Director, The Institute for Digital Medicine (WisDM) Head, Department of Biomedical Engineering, Department of Pharmacology, National University of Singapore
Dr Lim Jui , Chief Executive Officer, SGInnovate
Prof Louis Phee , Dean, College of Engineering, Tan Chin Tuan Centennial Professor, Nanyang Technological University
Others
Showcase on Medical Humanities (Broadcast Date – TBC)

Track Synopsis

The dualism of human nature is our greatest strength — but also poses the greatest challenge. When our individual potential is maximised therein lies fulfilment; however, working and living in a collective unit can bring about disenchantment, alienation, even burnout.

Navigating this tension is critical to understanding ourselves and the people around us, especially at a time when healthcare functions in a team-based, complex and dynamic environment. Utilizing an interdisciplinary approach drawing from the traditional humanities such as philosophy and sociology, together with the contemporary fields of modern psychology and organizational development, and situated squarely in healthcare scenarios, this session highlights the challenges of individualism vs collectivism, and explores how a better understanding of both may lead to renewed perspectives on wellbeing and flourishing.

The session is structured as a series of discussions featuring vignettes and common scenarios to prompt participants to think more deeply about individualism vs collectivism, to discern different perspectives on the “right” thing to do, and to come away with a more holistic conceptualisation of wellbeing. This session is based on a six-course course that has been successfully conducted among various healthcare professionals in NHG and maintains the original dialogic and interactive approach.

We welcome healthcare professionals from all family groups, especially those leading a unit or a department, and who have pondered how a better understanding of human nature can complement healthcare practice and our organizational life.

Track Lead :
Adj A/Prof Aaron Ang , Senior Consultant,Department of Psychiatry,Tan Tock Seng Hospital

Topic 1 : Q&A

Topic 2 : Part 1: What Makes Us Human?

Speaker :
Adj A/Prof Aaron Ang , Senior Consultant, Department of Psychiatry, Tan Tock Seng Hospital

Topic 3 : Insights from Respected Thought Leaders in Healthcare

Speaker :
Prof Chong Siow Ann , Senior Consultant, Early Psychosis Intervention Programme / Research / East Region, Institute of Mental Health

Topic 4 : Part 2: How Should We Live?

Speaker :
Adj A/Prof Aaron Ang , Senior Consultant, Department of Psychiatry, Tan Tock Seng Hospital

Topic 5 : Insights from Respected Thought Leaders in Healthcare

Speaker :
A/Prof Thomas Lew , Centre for Medical Technologies and Innovation (CMTi), National Healthcare Group Senior Consultant, Dept of Anaesthesiology, Intensive Care & Pain Medicine, Tan Tock Seng Hospital , Group Chief Digital Strategy Officer & Clinical Director,
“LIVE” Lunchtime Symposium

TRACK SYNOPSIS

Our nation continues to battle diabetes in the midst of the pandemic. In a recent national population health survey, diabetes prevalence amongst Singapore residents 18-79 years of age is 9.5%. Heart disease is a common complication for many patients with diabetes.

In the past few years since the launch of SGLT2 inhibitors, there has been a growing pool of evidence for the benefits of its use amongst patients with diabetes especially in reducing the burden of cardiac and renal complications. Our invited speaker Dr Lim Choon Pin will showcase the clinical use of these drugs in both diabetic and non-diabetic patients. 

Track Lead :
Dr Darren Seah , Senior Consultant Family Physician; Director, Family Medicine Development, National Healthcare Group Polyclinics
Chairperson :
Dr Darren Seah , Senior Consultant Family Physician; Director, Family Medicine Development, National Healthcare Group Polyclinics

Topic 1 : Q&A

Topic 2 : SGLT2i use amongst Patients with Heart Disease amongst Diabetics and Non Diabetic patients

Speaker :
Dr Lim Choon Pin , Consultant Cardiologist, The Heart and Vascular Centre
  • SGLT2 inhibitors have been shown to reduce cardiovascular outcomes in diabetic patients.
  • They have now also demonstrated to reduce CV mortality and heart failure hospitalisation in heart failure patients with or without diabetes.
  • SGLT2i has now become a one of the cornerstones of heart failure therapy in many international guidelines.
Top